TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pregnancy or live birth
Endpoint domain: Mortality/survival
Primary endpoint: emotional spectrum
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: EAT-26 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SWEAA scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: oxygen consumption at anaerobic threshold
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Burn scar outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of PONV within 48 hours after LSG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of clinically important PONV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postprandial insulin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Length-for-age z-score (LAZ) trajectory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stunting rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of LBW
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instrumental Activities of Daily Living (IADL) scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction in rhytid severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnosis performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean attenuation difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of adjustments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Increase in nonassisted painless mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic diversity (mean alleles per locus)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expected heterozygosity (HE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genetic differentiation index (FST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived control over treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Anxiety symptoms reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erosive area of oral lichen planus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient's pain index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean pain scores for eyelid retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of early onset basal cell carcinoma at tattoo site
Endpoint domain: Mortality/survival
Primary endpoint: Inpatient pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morphine milligram equivalents used after discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: survival from progression of IDH-mutated tumors
Endpoint domain: Mortality/survival
Primary endpoint: 30% decline in estimated glomerular filtration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Pelvic sidewall recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Other type of local recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: effectiveness of follow-up strategy of routine noninvasive stress testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: gene expression response to meals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric volume change (GCV) at T = 240 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Disease activity (ESSPRI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disease activity (ESSDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total B cells reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: grade ≥ 2 gastrointestinal acute toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: grade ≥ 2 late genitourinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: FFBP (Freedom from Biochemical Progression)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trust in intervention messages
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Decrease in YPIS total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in PSCD total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restorations' survival rates at 18 months
Endpoint domain: Mortality/survival
Primary endpoint: Efficacy and safety for transection of the liver parenchyma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cost of equipment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increase in alpha waves at occipital region
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Implementation effectiveness
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Marginal cost per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: fall-related self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: FMS competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate to vigorous PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (ORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Response maintained for at least 4 months (ORR4)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Attitude towards CBME assessments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfaction with CBLAS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Prognosis in patients with cardiac amyloidosis
Endpoint domain: Mortality/survival
Primary endpoint: Wound pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uterine contraction pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased chaos
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased meaning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased abstract flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine Disability Assessment Scale score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: vestibular migraine attack frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Painful bowel evacuation attempts reduction
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Inattention scale parental report
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Hyperactivity impulsivity scale parental report
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Homework Problems Checklist
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Neutralizing antibody geometric mean concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Vaccine efficacy against Covid-19
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinically effective
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placebo effects on symptom reporting
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: satisfaction with the overall procedure
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: 5-year cancer-specific survival rates
Endpoint domain: Mortality/survival
Primary endpoint: 5-year MFS rates
Endpoint domain: Mortality/survival
Primary endpoint: GSRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term failure of treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Change in daily SSB consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in students carrying a water bottle to school
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of weekly binge-eating episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence rates of PGCG
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of cutaneous dryness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: VAS pain scores in patients with dry skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: enrollment rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Willingness to consent for data storage in registry
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: recommendation intentions to people with pre-existing health conditions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: 3-point major adverse cardiovascular events (3P-MACE)
Endpoint domain: Mortality/survival
Primary endpoint: Overall response at week 24
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PO-SCORAD improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median percent change in serum LDL III concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum non-HDL-C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: serum TG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: knowledge difference between arms
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: decisional support
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: enrollment rate between arms
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Uterine artery Doppler median PI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Need for new antihypertensive drugs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: safety/effectiveness data
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: comparative costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of potentially inappropriate medications (PIMs) deprescribed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine attack times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interference of fatigue with daily life
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: incidence of surgical-site infection
Endpoint domain: Adverse events/effects
Primary endpoint: Critical health competences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: job demands
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: job control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: effort-reward imbalance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: overcommitment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Distribution of clinical outcomes according to the ordinal scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete clearance of treated warts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: blood lactate improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: base deficit improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: FACT/GOG-Ntx-12 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cumulative incidence of NCI-CTCAE grade ≥ 2 sensory neuropathy
Endpoint domain: Adverse events/effects
Primary endpoint: DBPrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: willingness-to-pay
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: incidence of uncomplicated malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: incidence of severe malaria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: node strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: betweenness centrality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hospitalization due to serious adverse events categorized as infections
Endpoint domain: Adverse events/effects
Primary endpoint: Postprandial TG concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cumulative criminal offense charge severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to achieve haemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Proportion of patients with HBV DNA <60 IU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in median alanine aminotransferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in bone mineral density at spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: serious hyperkalemia
Endpoint domain: Adverse events/effects
Primary endpoint: investigator-reported hyperkalemia
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor response at 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Root Coverage Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken for surgical procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Improvement in bladder function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in health status (KCCQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Parent acceptability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rates of completion and compliance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Costs in terms of parent and clinician time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: GAD-7 score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-36 score reduction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: psychomotor or mental developmental delay at 2 years of age
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Muscle activity levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: instantaneous functional connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: instantaneous effective connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tremor amplitude and frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Time in standing position
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvement of DCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: experimental scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSS improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PBI scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: MSIS‐29 improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nevirapine clearance (CL/F)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nevirapine trough concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity score of CRBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of intervention measured by PHQ-9 and CIDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater reliability of EDE subscales
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sarcopenia incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Adjusted all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of time patients were hypotensive during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of time with MAP <65 mm Hg
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patient-oriented composite outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Public confidence and trust in COVID-19 vaccinations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cognitive function (MMSE stability)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: discharge time from PACU
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Conformity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Homogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: interoception
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Assistance to light and very light smokers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adjusted prevalence of FL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adjusted prevalence of NAFLD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NASH liver-related deaths
Endpoint domain: Mortality/survival
Primary endpoint: Objective Structured Clinical Evaluation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Agreement of kinematic variables between indoor and outdoor running
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for summary format
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Symptom Severity Subscale (SSS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional Status Subscale (FSS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Incidence rate of thrombotic catheter dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: moderate/severe pain rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean water used (volume)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of mistakes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: harms at twelve months
Endpoint domain: Adverse events/effects
Primary endpoint: Fear scale decrease
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Anxiety scale decrease
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Morphine consumption in the post-anesthetic care unit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean differences of aerosol particles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical decision-making scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in diacylglycerol(FA16:0)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in triacylglycerol(FA22:1)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time-sensitive final diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in monthly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes